Abstract
There are two classes of tandem repeats in proteins - globular and non-globular. There are two subclasses of non-globular repeats. The first, such as collagen, form stable helices. Members of the second are flexible and somewhat disordered both in vitro and in vivo. This review focuses on this second subclass.
Keywords: Tandem repeats, intrinsically unstructured protein, structural change, ligand interaction, rapid evolution, concerted evolution
Protein & Peptide Letters
Title: Non-Globular Structures of Tandem Repeats in Proteins
Volume: 16 Issue: 11
Author(s): Norio Matsushima, Takanori Tanaka and Robert H. Kretsinger
Affiliation:
Keywords: Tandem repeats, intrinsically unstructured protein, structural change, ligand interaction, rapid evolution, concerted evolution
Abstract: There are two classes of tandem repeats in proteins - globular and non-globular. There are two subclasses of non-globular repeats. The first, such as collagen, form stable helices. Members of the second are flexible and somewhat disordered both in vitro and in vivo. This review focuses on this second subclass.
Export Options
About this article
Cite this article as:
Matsushima Norio, Tanaka Takanori and Kretsinger H. Robert, Non-Globular Structures of Tandem Repeats in Proteins, Protein & Peptide Letters 2009; 16 (11) . https://dx.doi.org/10.2174/092986609789353745
DOI https://dx.doi.org/10.2174/092986609789353745 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Data-driven Approach to Detect and Predict Adverse Drug Reactions
Current Pharmaceutical Design Actigraphy for Assessing Light Effects on Sleep and Circadian Activity Rhythm in Alzheimer's Dementia: A Narrative Review
Current Alzheimer Research α-Lipoic Acid Supplementation: A Tool for Obesity Therapy?
Current Pharmaceutical Design "Take and Run" and "Take and Hold" Therapeutical Electromagnetic Field Application Modalities in Physiotherapy: Some Clinically Significant Pathways of Action
Current Chemical Biology The Development of Preventives and Therapeutics for Alzheimers Disease that Inhibit the Formation of β-Amyloid Fibrils (fAβ), as Well as Destabilize Preformed fAβ
Current Pharmaceutical Design Nicotinic Receptors in Neurodegeneration
Current Neuropharmacology Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases
Mini-Reviews in Medicinal Chemistry Treatment of Catatonia with Asenapine in a Patient with Schizotypal Personality Disorder, Psychotic Depression and Septic Shock from SARSCoV- 2 - A Case Report
CNS & Neurological Disorders - Drug Targets Activation of Latent HIV-1 Expression by Protein Kinase C Agonists. A Novel Therapeutic Approach to Eradicate HIV-1 Reservoirs
Current Drug Targets Telomerase Therapeutics for Degenerative Diseases
Current Molecular Medicine Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Omega-3 Polyunsaturated Fatty Acids in Alzheimers Disease: Key Questions and Partial Answers
Current Alzheimer Research Antibodies As Promising Novel Neuroprotective Agents in the Central Nervous System Injuries
Central Nervous System Agents in Medicinal Chemistry Cholesterol Lowering Therapy: Treat to Target or Reduce the Global Risk? The Unresolved Problem of Residual Risk
Current Pharmaceutical Design Acute Stroke Therapy: Combination Drugs and Multifunctional Neuroprotectants
Current Neuropharmacology Does an Interdisciplinary Network Improve Dementia Care? Results from the IDemUck-Study
Current Alzheimer Research Meet Our Editorial Board Member
Current Alzheimer Research Adverse Effects of Statins - Myths and Reality
Current Pharmaceutical Design Environmental Enrichment as a Positive Behavioral Intervention Across the Lifespan
Current Neuropharmacology Epigenetic Changes in the Methylation Patterns of KCNQ1 and WT1 after a Weight Loss Intervention Program in Obese Stroke Patients
Current Neurovascular Research